Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010:3:95-101.
doi: 10.2147/IDR.S6961. Epub 2010 Aug 30.

Daptomycin: a novel lipopeptide antibiotic against Gram-positive pathogens

Andres Beiras-Fernandez  1 , Ferdinand Vogt, Ralf Sodian, Florian Weis
Affiliations

Daptomycin: a novel lipopeptide antibiotic against Gram-positive pathogens

Andres Beiras-Fernandez et al. Infect Drug Resist. 2010.

Abstract

The aim of this review is to summarize the historical background of drug resistance of Gram-positive pathogens as well as to describe in detail the novel lipopeptide antibiotic daptomycin. Pharmacological and pharmacokinetic aspects are reviewed and the current clinical use of daptomycin is presented. Daptomycin seems to be a reliable drug in the treatment of complicated skin and skin structure infections, infective right-sided endocarditis, and bacteremia caused by Gram-positive agents. Its unique mechanism of action and its low resistance profile, together with its rapid bactericidal action make it a favorable alternative to vancomycin in multi-drug resistant cocci. The role of daptomycin in the treatment of prosthetic material infections, osteomyelitis, and urogenital infections needs to be evaluated in randomized clinical trials.

Keywords: daptomycin; left-sided endocarditis; methicillin-resistant Staphylococcus aureus (MRSA); multi-drug resistance; pneumonia; urinary tract infection.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Chemical structure of daptomycin.
See this image and copyright information in PMC

References

    1. Enoch DA, Bygott JM, Daly ML, Karas JA. Daptomycin. J Infect. 2007;55:205–213. - PubMed
    1. Novartis Europharm Ltd Summary of Product Characteristics. 2009
    1. Kanafani ZA, Corey GR. Daptomycin: a rapidly bactericidal lipopeptide for the treatment of Gram-positive infections. Expert Rev Anti Infect Ther. 2007;5:177–184. - PubMed
    1. Fielding J. History of penicillin. Lancet. 1980;1:43–44. - PubMed
    1. Gots JS. The detection of penicillinases-producing properties of microorganisms. Science. 1945;102:309. - PubMed